학술논문
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy
Document Type
Article
Author
Source
In Annals of Oncology September 2016 27(9):1794-1799
Subject
Language
ISSN
0923-7534